eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Novartis Pharmaceuticals Corp. - Comment
Novartis Pharmaceuticals Corp. - Comment
Document ID:
FDA-2011-N-0079-0003
Document Type:
Public Submission
Agency:
Food And Drug Administration
Received Date:
July 12 2011, at 12:00 AM Eastern Daylight Time
Date Posted:
July 14 2011, at 12:00 AM Eastern Standard Time
Comment Start Date:
April 13 2011, at 12:00 AM Eastern Standard Time
Comment Due Date:
July 12 2011, at 11:59 PM Eastern Standard Time
Tracking Number:
80ec0a15
View Document:
This is comment on Proposed Rule
Disqualification of a Clinical Investigator
View Comment
Please see attached Novartis Pharmaceutical Corp. regarding the proposed rule for disqualification of a clinical investigator
Attachments:
NVS comments -disqualified investigator
Title:
NVS comments -disqualified investigator
View Attachment:
Related Comments
Total:
2
Boontaricka K Kanranu - Comment
Public Submission
Posted:
05/17/2011
ID:
FDA-2011-N-0079-0002
Comment Period Closed
Jul 12,2011 11:59 PM ET
Novartis Pharmaceuticals Corp. - Comment
Public Submission
Posted:
07/14/2011
ID:
FDA-2011-N-0079-0003
Comment Period Closed
Jul 12,2011 11:59 PM ET
Novartis Pharmaceuticals Corp. - Comment
This is comment on Proposed Rule
Disqualification of a Clinical Investigator
View Comment
Attachments:
NVS comments -disqualified investigator
Title:
NVS comments -disqualified investigator
Related Comments
Public Submission Posted: 05/17/2011 ID: FDA-2011-N-0079-0002
Jul 12,2011 11:59 PM ET
Public Submission Posted: 07/14/2011 ID: FDA-2011-N-0079-0003
Jul 12,2011 11:59 PM ET